DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Merck and the FDA.
Pembrolizumab: Combined FDA and Applicant ODAC Briefing Document for the Oncologic Drugs Advisory Committee (ODAC) Meeting on February 9, 2021.
Accessed February 20, 2021 at:
https://www.fda.gov/media/145654/download
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.